Buprenorphine (sublingual formulation)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Buprenorphine (sublingual formulation), covering 2018-12-31 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) [Phase 3]